The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromes.


Journal Article (Review)

Dyslipidemia and hyperglycemia are common among patients presenting with acute coronary syndromes (ACS), and patients with ACS and metabolic disorders are at increased risk for worse outcomes. Although guidelines for the diagnosis and management of dyslipidemia, diabetes, and the metabolic syndrome have been published, these guidelines have not specifically focused on the ACS patient population. Recent observational registries and clinical trials have advanced the appreciation of these disorders in ACS populations and data from these studies support aggressive efforts to diagnose and treat dyslipidemia and hyperglycemia in patients admitted for ACS.

Full Text

Cited Authors

  • Goyal, A; Petersen, JL; Mahaffey, KW

Published Date

  • July 1, 2004

Published In

Volume / Issue

  • 6 / 4

Start / End Page

  • 300 - 307

PubMed ID

  • 15182608

Pubmed Central ID

  • 15182608

Electronic International Standard Serial Number (EISSN)

  • 1534-3170

International Standard Serial Number (ISSN)

  • 1523-3782

Digital Object Identifier (DOI)

  • 10.1007/s11886-004-0080-1


  • eng